Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis-Reference-Cited by-同舟云学术

Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis

Published:2021-12 Issue:13 Volume:37 Page:110146
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Yucer Nur,Ahdoot Rodney,Workman Michael J.,Laperle Alexander H.,Recouvreux Maria S.^ORCID,Kurowski Kathleen^ORCID,Naboulsi Diana J.,Liang Victoria,Qu Ying,Plummer Jasmine T.^ORCID,Gayther Simon A.,Orsulic Sandra^ORCID,Karlan Beth Y.^ORCID,Svendsen Clive N.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference78 articles.

1. Predicting biomarkers for ovarian cancer using gene-expression microarrays;Adib;Br. J. Cancer,2004

2. Detecting differential usage of exons from RNA-seq data;Anders;Genome Res.,2012

3. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer;Anttila;Cancer Res.,2000

4. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines;Barrett;Stem Cells Transl. Med.,2014

5. New tumor markers: CA125 and beyond;Bast;Int. J. Gynecol. Cancer,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5 mC modification of steroid hormone biosynthesis-related genes orchestrates feminization of channel catfish induced by high-temperature;Environmental Pollution;2024-09

2. Organoids for Cancer Research: Advances and Challenges;Advanced Biology;2024-07-08

3. Optimizing Nodal, Wnt and BMP signaling pathways for robust and efficient differentiation of human induced pluripotent stem cells to intermediate mesoderm cells;Frontiers in Cell and Developmental Biology;2024-06-03

4. Serum CA125 and HE4 levels combined with magnetic resonance imaging (MRI) in the clinical diagnostic value of ovarian neoplasms;Journal of Radiation Research and Applied Sciences;2024-06

5. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment;Journal of Cancer Research and Clinical Oncology;2024-03-20